Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231

Veterinary Clinics of North America - Small Animal Practice

Volumn 26, Issue 1, 1996, Pages 73-85

  Jeglum, K A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 231; UNCLASSIFIED DRUG; VINCRISTINE;

CANCER IMMUNOTHERAPY; DOG; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

CANIS FAMILIARIS;

EID: 0030029203     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(96)50007-0     Document Type: Review

References (19)

1. J.O. Armitage Treatment of non-Hodgkin’s lymphoma N Engl J Med 328 1993 1023 1030
2. R.F. Carter C.K. Harris S.J. Withrow Chemotherapy of canine lymphoma with histopathological correlation: Doxorubicin alone compared to COP as first treatment regimefi J Am Anim Hosp 23 1987 587 596
3. J.M. Dobson N.T. Gorman Canine multicentric lymphoma 2: Comparison of response to two chemotherapeutic protocols J Small Anim Pract 35 1994 9 15
4. P.G. Greenlee D.A. Filippa F.W. Quimby Lymphoma in dogs. A morphologic, immunologic, and clinical study Cancer 66 1990 480 490
5. K.A. Hahn R.C. Richardson R.F. Teclaw Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma? J Vet Intern Med 6 1992 2 10
6. K.A. Jeglum K.M. Young K. Barnsley Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma Cancer 61 1988 2042 2050
7. E.T. Keller E.G. MacEwen R.C. Rosenthal Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma J Vet Intern Med 7 1993 289 295
8. K.A. Jeglum K.M. Young K. Barnsley Chemotherapy Versus Chemotherapy with Intralymphatic Tumor Cell Vaccine in Canine Lymphoma Cancer 61 1988 2042 2050
9. K.A. Jeglum Z. Steplewski University of Pennsylvania School of Veterinary Medicine, et al: Canine Lymphoma: A Model for Clinical Trials of Cytotoxic Murine Monoclonal Antibodies (abstract 1677) In the Proceedings of the 79th Annual Meeting of the American Association for Cancer Research, New Orleans, LA 1988 421
10. L.W. Kwak M.L. Grossbard W.J. Urba Clinical applications of monoclonal antibodies in cancer; B-cell lymphomas V.T. DeVita S. Hellman S.A. Rosenberg Biologic Therapy of Cancer ed 2 1995 Lippincott Philadelphia 553
11. E.G. MacEwen A.A. Hayes S. Mooney Levamisole as an adjuvant to chemotherapy for canine lymphosarcoma J Biol Resp Modif 4 1985 427 433
12. E.G. MacEwen A.A. Hayes R.E. Matus Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases J Am Vet Med Assoc 190 1978–1981 564 568
13. G.S. Price R.L. Page B.M. Fischer Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma J Vet Intern Med 5 1991 259 262
14. C. Rosales K.A. Jeglum M. Obrocka Cytolytic Activity of Murine Anti-dog Lymphoma Monoclonal Antibodies with Canine Effector Cells and Complement Cell Immunol 115 1988 420 428
15. M.P. Rosenberg R.E. Matus A.K. Patnaik Prognostic factors in dogs with lymphoma and associated hypercalcemia J Vet Intern Med 5 1991 268 271
16. Z. Steplewski K.A. Jeglum C. Rosales Canine lymphoma-associated antigens defined by murine monoclonal antibodies Cancer Immunol Immunother 24 1987 197 201
17. E. Teske P. van Heerde G.R. Rutteman Prognostic factors for treatment of malignant lymphoma in dogs J Am Vet Med Assoc 205 1994 1722 1728
18. G.H. Theilen M. Worley E. Benjamini Chemoimmunotherapy for canine lymphosarcoma J Am Vet Med Assoc 170 1977 607 610
19. R.E. Weller G.H. Theilen B.R. Madewell Chemoimmunotherapy for canine lymphosarcoma: A prospective evaluation of specific and nonspecific immunomodulation Am J Vet Res 41 1980 516 521